Harhaji Ljubica, Isakovic Aleksandra, Raicevic Nevena, Markovic Zoran, Todorovic-Markovic Biljana, Nikolic Nadezda, Vranjes-Djuric Sanja, Markovic Ivanka, Trajkovic Vladimir
Institute for Biological Research, Belgrade, Serbia and Montenegro.
Eur J Pharmacol. 2007 Jul 30;568(1-3):89-98. doi: 10.1016/j.ejphar.2007.04.041. Epub 2007 Apr 30.
Using the rat glioma cell line C6 and the human glioma cell line U251, we demonstrate the multiple mechanisms underlying the in vitro anticancer effects of the C(60) fullerene water suspension (nano-C(60) or nC(60)) produced by solvent exchange method. Nano-C(60) in a dose-dependent manner reduced the tumor cell numbers after 24 h of incubation. The observed antiglioma action of nC(60) at high concentration (1 microg/ml) was due to a reactive oxygen species-mediated necrotic cell damage that was partly dependent on oxidative stress-induced activation of extracellular signal-regulated kinase (ERK). On the other hand, low-dose nC(60) (0.25 microg/ml) did not induce either necrotic or apoptotic cell death, but caused oxidative stress/ERK-independent cell cycle block in G(2)/M phase and subsequent inhibition of tumor cell proliferation. Treatment with either high-dose or low-dose nC(60) caused the appearance of acidified intracytoplasmic vesicles indicative of autophagy, but only the antiglioma effect of low-dose nC(60) was significantly attenuated by inhibiting autophagy with bafilomycin A1. Importantly, primary rat astrocytes were less sensitive than their transformed counterparts to a cytostatic action of low-dose nC(60). These data provide grounds for further development of nC(60) as an anticancer agent.
我们使用大鼠胶质瘤细胞系C6和人胶质瘤细胞系U251,证明了通过溶剂交换法制备的C60富勒烯水悬浮液(纳米C60或nC60)体外抗癌作用的多种机制。孵育24小时后,纳米C60以剂量依赖的方式减少了肿瘤细胞数量。在高浓度(1微克/毫升)下观察到的nC60的抗胶质瘤作用是由于活性氧介导的坏死性细胞损伤,这部分依赖于氧化应激诱导的细胞外信号调节激酶(ERK)激活。另一方面,低剂量nC60(0.25微克/毫升)既不诱导坏死性也不诱导凋亡性细胞死亡,但导致氧化应激/ERK非依赖性细胞周期阻滞在G2/M期,并随后抑制肿瘤细胞增殖。高剂量或低剂量nC60处理均导致酸化的胞浆内小泡出现,提示自噬,但只有低剂量nC60的抗胶质瘤作用被巴弗洛霉素A1抑制自噬后显著减弱。重要的是,原代大鼠星形胶质细胞比其转化后的细胞对低剂量nC60的细胞生长抑制作用更不敏感。这些数据为进一步开发nC60作为抗癌药物提供了依据。